TAMIFLU (OSELTAMIVIR PHOSPHATE) MARKET ANALYSIS
Global Tamiflu (Oseltamivir Phosphate) Market: Key Developments
On December 7, 2022, Genentech, Inc., a U.S. Biotechnology Corporation, announced that Tamiflu (oseltamivir phosphate) is available across the U.S. for the distributors to ship the drugs across the U.S. pharmacies. This will increase the customer base for the drug, and this is expected to increase the growth of the market over the forecast period
In December 2021, Sun Pharmaceutical Industries, a pharmaceutical company, set up a new manufacturing facility in Andhra Pradesh, India. This is expected to increase in the production of generic drugs, including drugs for the treatment of influenza, which will drive the growth of the market, over the forecast period
In July 2020, Teva Pharmaceutical Industries Ltd., a pharmaceutical company, who entered in the Japanese market, by entering into joint venture with Takeda Pharmaceutical Company, a pharmaceutical company, announced plans for new strategy for its local commercial operations, the new strategy will focus on marketing of generic drugs, in the Japanese market, including, generic version of oseltamivir phosphate tablets. This is expansion strategy is expected to drive the growth of the market over the forecast period.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
